Coronary stents are small wired mesh-like medical interventional devices used for treatment of narrowed arteries. Increasing incidence of coronary blockage and changes in lifestyle from physically active to sedentary lifestyle, in turn is increasing cholesterol accumulation, and in turn aiding the coronary stents market growth. For instance, according to World Health Organization (WHO) 2017 survey, the global prevalence of obesity increased by three times between 1975 and 2016. The trajectory growth in the coronary stents market can be attributed to increasing number of product launches in the market. Intense competition and pricing pressure is compelling manufacturers to develop cost-effective and innovative stents in the market.
Download PDF Brochure of Research Report: https://www.coherentmarketinsights.com/insight/request-pdf/2031
For instance, in 2017, Medtronic received approval for Onyx drug eluting stents from the U.S. FDA for the treatment of coronary artery disease in adults. In the same year, company also received approval for cobalt chromium coronary stent system, known as Pro-Kinetic energy stents after BIOHELIX-I studies.
Furthermore, in 2017, Cordis launched two products: the Tryton Side Branch Stent and Medinol’s NIRxcell, a cobalt-chromium bare metal stent (BMS) under comprehensive interventional cardiology portfolio at 29th Transcatheter Cardiovascular Therapeutics Symposium. Such product launches in symposiums and conferences are expected to highlight the product and its features to healthcare professionals and distributors, in turn aiding in increasing the customer base of the company.
Browse Market Data 32 Tables and 30 Figures spread through 155 Pages and in-depth TOC on “Coronary Stents Market, by Product Type (Bare-metal Stents, Drug Eluting Stents, and Bioabsorbable Stents), by Material (Metallic (Stainless Steel, Silicon Carbide, Titanium Nitride Oxide, Cobalt Chromium, Platinum Chromium, and Others) and Polymeric (Non-degradable / Permanent Stents and Degradable / Temporary Stents)), by End User (Hospitals, Specialty Clinics and Ambulatory Surgical Centers) and by Region – Global Forecast to 2026”
The Global Coronary Stents Market by Product Type (Bare-metal Stents, Drug Eluting Stents, and Bioabsorbable Stents), by Material (Metallic (Stainless Steel, Silicon Carbide, Titanium Nitride Oxide, Cobalt Chromium, Platinum Chromium, and Others) and Polymeric (Non-degradable / Permanent Stents and Degradable / Temporary Stents)), by End User (Hospitals, Specialty Clinics, and Ambulatory Surgical Centers) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) is estimated to be valued at US$ 7,814.4 million in 2018, and is projected to exhibit a CAGR of 6.8% over the forecast period (2018 – 2026) as highlighted in a new report published by Coherent Market Insights.
Polymeric stents segment is expected to exhibit the highest CAGR, over the forecast period, owing to its benefits over metallic stents encouraging more product launches in this segment. Metallic stents leads to complications such as thrombosis or hyper-reactivity which are less common in polymeric stents as they are more biocompatible.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Coherent Market Insights
1001 4th Ave,
Seattle, WA 98154